PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
29/05/2026
Voltar para busca
Dado oficial do USPTO
MOSAIQ
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MOSAIQ
ST13
US500000086178459Classe
1, 5, 9, 10
Pedido
86178459
Registro
4820522
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
30/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
29/01/2014
Data de registro
29/09/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/01/2022
Última transação
30/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
11
Localização do titular
St Helier, GB
Examinador
SOBRAL, CHRISTINA
Localização atual
Historical data usage
Titulares e representantes
Titulares
QBD (QS IP) Limited
Representantes
Katrina G. Hull Markery Law LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations for scientific or research use provided as part of a kit; test kits consisting of diagnostic preparations for scientific or research use; diagnostic reagents and diagnostic reagents for analytical, scientific and industrial use; diagnostic assay preparation, namely, assays, for scientific, industrial and research purposes
Classe 5
Diagnostic reagents derived from blood or in-vitro culture for medical diagnostic purposes; protein based microarrays for medical diagnostic purposes in the nature of antigen typing and antibody identification, blood grouping and disease screening; protein based microarrays for in-vitro testing for medical diagnostic purposes; diagnostic reagents for medical use; chemical reagents for medical diagnosis and analysis; diagnostic assay preparations in the nature of assays and substances in the nature of reagents for blood grouping and disease screening for clinical and medical use; medical diagnostic reagents for testing blood, blood components and plasma for clinical and medical use; medical diagnostic reagents for clinical and medical use as control agents for in vitro diagnostic tests; medical diagnostic reagents for clinical and medical use for virology screening for donor blood; medical diagnostic assays for clinical and medical use for antigen typing and antibody identification, blood grouping and disease screening; diagnostic preparations and kits comprised of medical diagnostic reagents for sensitivity testing, quality control and proficiency testing in relation to diagnostic techniques, processes and instruments, all for clinical medical use
Classe 9
Scientific research and laboratory apparatus for diagnostic testing in the nature of antigen typing and antibody identification, blood grouping and disease screening; Laboratory equipment, namely, microarrays; none of the aforesaid relating to electronic medical records and software for electronic medical records
Classe 10
Medical diagnostic testing instruments for blood typing; Medical diagnostic testing instruments for screening blood and blood products; Medical diagnostic testing instruments for antigen typing; Medical diagnostic testing instruments for antibody identification, blood grouping and disease screening; microarrays in the form of medical testing instruments for in-vitro testing
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/05/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
25/03/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
29/09/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/03/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/01/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/01/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/01/2022
E815
TEAS SECTION 8 & 15 RECEIVED
29/09/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
13/07/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/07/2021
ES7R
TEAS SECTION 7 REQUEST RECEIVED
12/03/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29/09/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/09/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
23/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/09/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/09/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
29/09/2015
PUBO
PUBLISHED FOR OPPOSITION
14/07/2015
NPUB
NOTICE OF PUBLICATION
24/06/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/06/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
22/05/2015
CNSL
LETTER OF SUSPENSION MAILED
03/03/2015
CNSL
SUSPENSION LETTER WRITTEN
03/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/03/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/03/2015
CNFR
FINAL REFUSAL MAILED
02/12/2014
CNFR
FINAL REFUSAL WRITTEN
01/12/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/10/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/10/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/10/2014
CNRT
NON-FINAL ACTION MAILED
05/05/2014
CNRT
NON-FINAL ACTION WRITTEN
05/05/2014
DOCK
ASSIGNED TO EXAMINER
05/05/2014
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
14/02/2014
ALIE
ASSIGNED TO LIE
12/02/2014
MPMK
NOTICE OF PSEUDO MARK MAILED
11/02/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/02/2014
ALIE
ASSIGNED TO LIE
06/02/2014
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/02/2014
NWAP
NEW APPLICATION ENTERED
01/02/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MOSAIQ ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.